Literature DB >> 20109445

PEGylated interferon-beta modulates the acute inflammatory response and recovery when combined with forced exercise following cervical spinal contusion injury.

Harra R Sandrow-Feinberg1, Victoria Zhukareva, Lauren Santi, Kassi Miller, Jed S Shumsky, Darren P Baker, John D Houle.   

Abstract

Secondary degeneration leads to an expansion of the initial tissue damage sustained during a spinal cord injury (SCI). Dampening the cellular inflammatory response that contributes to this progressive tissue damage is one possible strategy for neuroprotection after acute SCI. We initially examined whether treatment with a PEGylated form of rat interferon-beta (IFN-beta) would modulate the expression of several markers of inflammation and neuroprotection at the site of a unilateral cervical level 5 contusion injury. Adult female Sprague-Dawley rats were injured using the Infinite Horizon Impactor at a force of 200 kdyn (equivalent to a severe injury) and a mean displacement of 1600-1800 mum. A single dose (5x10(6) units) of PEGylated IFN-beta or vehicle was administered 30 min following SCI. Here we demonstrate temporal changes in pro- and anti-inflammatory cytokine levels and the expression of heat shock proteins and iNOS (involved in neuroprotection) at the lesion epicenter and one segment caudally after SCI and PEG IFN-beta treatment. The results suggested a potential therapeutic treatment strategy for modulation of secondary damage after acute SCI. Therefore, we examined whether acute treatment with PEG IFN-beta would improve forelimb function alone or when combined with forced exercise (Ex). Animals began the Ex paradigm 5 days post SCI and continued for 5 days/week over 8 weeks. Locomotion (forelimb locomotor scale [FLS], hindlimb BBB, and TreadScan) and sensorimotor function (grid walking) was tested weekly. Additional outcome measures included lesion size and glial cell reactivity. Significant FLS improvements occurred at 1 week post SCI in the PEGylated IFN-beta-treated group but not at any other time point or with any other treatment approaches. These results suggest that this acute neuroprotective treatment strategy does not translate into long term behavioral recovery even when combined with forced exercise. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109445      PMCID: PMC2864368          DOI: 10.1016/j.expneurol.2010.01.009

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  54 in total

1.  Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: relevance to MS.

Authors:  S Chabot; V W Yong
Journal:  Neurology       Date:  2000-11-28       Impact factor: 9.910

2.  Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway.

Authors:  Masamichi Katori; Roland Buelow; Bibo Ke; Jeff Ma; Ana J Coito; Suhasini Iyer; Daniel Southard; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2002-01-27       Impact factor: 4.939

3.  Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats.

Authors:  J R Bethea; H Nagashima; M C Acosta; C Briceno; F Gomez; A E Marcillo; K Loor; J Green; W D Dietrich
Journal:  J Neurotrauma       Date:  1999-10       Impact factor: 5.269

4.  Heme oxygenase-1 expression after spinal cord injury: the induction in activated neutrophils.

Authors:  Yi Liu; Toshiya Tachibana; Yi Dai; Eiji Kondo; Tetsuo Fukuoka; Hiroki Yamanaka; Koichi Noguchi
Journal:  J Neurotrauma       Date:  2002-04       Impact factor: 5.269

5.  Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity.

Authors:  Fernando Gómez-Pinilla; Zhe Ying; Roland R Roy; Raffaella Molteni; V Reggie Edgerton
Journal:  J Neurophysiol       Date:  2002-11       Impact factor: 2.714

6.  Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis.

Authors:  K Mehindate; D J Sahlas; D Frankel; Y Mawal; A Liberman; J Corcos; S Dion; H M Schipper
Journal:  J Neurochem       Date:  2001-06       Impact factor: 5.372

Review 7.  Update on the treatment of spinal cord injury.

Authors:  Darryl C Baptiste; Michael G Fehlings
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

8.  The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death.

Authors:  Mohammed T Akbar; Anna M C Lundberg; Ke Liu; Sharmili Vidyadaran; Kim E Wells; Hamid Dolatshad; Sarah Wynn; Dominic J Wells; David S Latchman; Jacqueline de Belleroche
Journal:  J Biol Chem       Date:  2003-03-13       Impact factor: 5.157

9.  Interplay between brain-derived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity.

Authors:  S Vaynman; Z Ying; F Gomez-Pinilla
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

10.  Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.

Authors:  Maryna Yushchenko; Michael Mäder; Ercan Elitok; Andreas Bitsch; Alexander Dressel; Hayrettin Tumani; Timon Bogumil; Bernd Kitze; Sigrid Poser; Frank Weber
Journal:  J Neurol       Date:  2003-10       Impact factor: 4.849

View more
  8 in total

1.  Characterization of a graded cervical hemicontusion spinal cord injury model in adult male rats.

Authors:  Kelly A Dunham; Akkradate Siriphorn; Supin Chompoopong; Candace L Floyd
Journal:  J Neurotrauma       Date:  2010-11       Impact factor: 5.269

2.  Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury.

Authors:  Angelo C Lepore
Journal:  J Vis Exp       Date:  2011-09-18       Impact factor: 1.355

3.  Interferon-β Plays a Detrimental Role in Experimental Traumatic Brain Injury by Enhancing Neuroinflammation That Drives Chronic Neurodegeneration.

Authors:  James P Barrett; Rebecca J Henry; Kari Ann Shirey; Sarah J Doran; Oleg D Makarevich; Rodney M Ritzel; Victoria A Meadows; Stefanie N Vogel; Alan I Faden; Bogdan A Stoica; David J Loane
Journal:  J Neurosci       Date:  2020-02-06       Impact factor: 6.167

4.  Amphetamine-enhanced motor training after cervical contusion injury.

Authors:  Laura Krisa; Kelly L Frederick; John C Canver; Scott K Stackhouse; Jed S Shumsky; Marion Murray
Journal:  J Neurotrauma       Date:  2011-09-19       Impact factor: 5.269

5.  Human iPS cell-derived astrocyte transplants preserve respiratory function after spinal cord injury.

Authors:  Ke Li; Elham Javed; Daniel Scura; Tamara J Hala; Suneil Seetharam; Aditi Falnikar; Jean-Philippe Richard; Ashley Chorath; Nicholas J Maragakis; Megan C Wright; Angelo C Lepore
Journal:  Exp Neurol       Date:  2015-07-26       Impact factor: 5.330

6.  Chronic at-level thermal hyperalgesia following rat cervical contusion spinal cord injury is accompanied by neuronal and astrocyte activation and loss of the astrocyte glutamate transporter, GLT1, in superficial dorsal horn.

Authors:  Rajarshi Putatunda; Tamara J Hala; Jeannie Chin; Angelo C Lepore
Journal:  Brain Res       Date:  2014-05-14       Impact factor: 3.252

Review 7.  Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application.

Authors:  Francesco Roselli; Akila Chandrasekar; Maria C Morganti-Kossmann
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

Review 8.  Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration.

Authors:  Daniel J Hellenbrand; Charles M Quinn; Zachariah J Piper; Carolyn N Morehouse; Jordyn A Fixel; Amgad S Hanna
Journal:  J Neuroinflammation       Date:  2021-12-07       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.